PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825FJD46
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $31,095
Award facts
- Contract value 100% obligated
- $31,094.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,094.70 by the Defense Logistics Agency's Medical Supply Chain on September 6, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award involves no set-aside designation and was competitively awarded through open competition. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies comprehensive pharmaceutical products and medical supplies to support military and veteran healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
This delivery order exemplifies AmerisourceBergen Drug Corp's ongoing role as a prime vendor supporting the Defense Health Agency and other federal healthcare systems. The contract's performance location in Conshohocken, Pennsylvania reflects the company's headquarters operations and distribution capabilities. The firm fixed-price structure and relatively modest individual order value demonstrate the operational flexibility of the larger SPE2DX IDC vehicle, which enables the company to fulfill diverse pharmaceutical and medical supply requirements for military healthcare programs worldwide. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to establish multiple regional contracts with separate contractors, positioning AmerisourceBergen Drug Corp as a key supplier within the federal medical procurement landscape.
Quick answers
Who was awarded contract SPE2D825FJD46?
SPE2D825FJD46 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 6, 2025.
How much is contract SPE2D825FJD46 worth?
The government has obligated $31,095 on SPE2D825FJD46.
Is contract SPE2D825FJD46 an order under another contract?
Yes. SPE2D825FJD46 is a delivery order under SPE2DX22D0019, an indefinite delivery contract.
Was contract SPE2D825FJD46 competed?
The extent of competition for SPE2D825FJD46 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award